Alcon’s Clareon Vivity IOL gains CE Mark approval, expanding vision correction options in Europe
Discover how Alcon’s Clareon Vivity IOL is transforming cataract surgery with CE Mark approval, offering presbyopia correction and extended vision clarity in Europe. Read More
Glenmark Pharmaceuticals expands U.S. OTC market presence with Olopatadine Eye Drops
Glenmark secures FDA approval for its OTC Olopatadine Hydrochloride eye drops, expanding its U.S. presence in the $50.7M allergy relief market. Read More
Alcon acquires Aerie Pharmaceuticals to expand eye care business
Alcon, an American Swiss medical company specializing in eye care products, has closed the previously announced $930 million acquisition of Aerie Pharmaceuticals, a NASDAQ-based pharmaceutical ... Read More
Alcon launches AcrySof IQ PanOptix trifocal intraocular lens for cataract surgery patients in US
Alcon, a leading global eye care company, has introduced its AcrySof IQ PanOptix trifocal intraocular lens (IOL) in the United States. This launch marks a ... Read More